INT171366

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.18
First Reported 2002
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 0.63
Pain Relevance 0.66

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (Insr) endosome (Insr) plasma membrane (Insr)
nucleus (Insr) kinase activity (Insr)
Insr (Mus musculus)
Pain Link Frequency Relevance Heat
Opioid 46 99.52 Very High Very High Very High
antagonist 28 95.56 Very High Very High Very High
opioid receptor 24 48.12 Quite Low
agonist 16 5.00 Very Low Very Low Very Low
MU agonist 8 5.00 Very Low Very Low Very Low
Enkephalin 4 5.00 Very Low Very Low Very Low
substance P 4 5.00 Very Low Very Low Very Low
tolerance 3 5.00 Very Low Very Low Very Low
orphanin 2 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Glioma 26 97.92 Very High Very High Very High
Cytomegalovirus Infection 5 82.44 Quite High
Targeted Disruption 18 5.00 Very Low Very Low Very Low
Toxicity 10 5.00 Very Low Very Low Very Low
Congenital Anomalies 9 5.00 Very Low Very Low Very Low
Arrhythmias 2 Under Development 8 5.00 Very Low Very Low Very Low
Heart Disease 4 5.00 Very Low Very Low Very Low
Sprains And Strains 4 5.00 Very Low Very Low Very Low
Cv General 2 Under Development 4 5.00 Very Low Very Low Very Low
Frailty 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The sequences of the primers used for the amplification of insulin receptor (IR), cardiac troponin T (cTNT) and GAPDH RNAs are: IR (forward 5?
Positive_regulation (used) of Localization (amplification) of IR
1) Confidence 0.18 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2597774 Disease Relevance 0.15 Pain Relevance 0
Potential of endogenously expressed insulin receptors (IR) and PDGFR to act as surrogate protein scaffolds during ERK activation by ?
Positive_regulation (activation) of Localization (act) of IR
2) Confidence 0.08 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC88976 Disease Relevance 0.24 Pain Relevance 0.33
Potential of endogenously expressed insulin receptors (IR) and PDGFR to act as surrogate protein scaffolds during ERK activation by ?
Positive_regulation (during) of Localization (act) of IR
3) Confidence 0.08 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC88976 Disease Relevance 0.24 Pain Relevance 0.33

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox